A clinical and epidemiological review of non-toxigenic Clostridium difficile

被引:51
|
作者
Natarajan, Mukil [1 ]
Walk, Seth T. [1 ,2 ]
Young, Vincent B. [1 ,3 ]
Aronoff, David M. [1 ,3 ]
机构
[1] Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA
[3] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Clostridium difficile; Non-toxigenic Clostridium difficile; Probiotic; Hamsters; Humans; CLINDAMYCIN-ASSOCIATED COLITIS; FIELD GEL-ELECTROPHORESIS; INTENSIVE-CARE-UNIT; TOXIN-B; PSEUDOMEMBRANOUS COLITIS; PATHOGENIC STRAINS; COLONIZATION; PREVALENCE; HAMSTERS; DIARRHEA;
D O I
10.1016/j.anaerobe.2013.05.005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Clostridium difficile is a significant nosocomial threat to human health and is the most commonly identified cause of antibiotic-associated diarrhea. The development of C difficile colitis requires production of toxins A and/or B, but some strains do not express these proteins. These non-toxigenic C difficile (NTCD) have garnered attention for their capacity to colonize humans and potentially reduce the risk for symptomatic colitis caused by toxigenic strains. Isolates of NTCD have been obtained from the environment as well as from animal and human sources. Studies in a hamster CDI model have demonstrated a protective effect of NTCD against toxigenic infection. The extent to which this protective effect of NTCD occurs in humans remains to be defined. Evidence for a therapeutic or preventive role for NTCD is limited but clinical prophylaxis studies are ongoing. NTCD potentially represents an exciting new tool in preventing CDI and its recurrences. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [1] CLINICAL IMPORTANCE AND REPRESENTATION OF TOXIGENIC AND NON-TOXIGENIC CLOSTRIDIUM DIFFICILE CULTIVATED FROM STOOL SAMPLES OF HOSPITALIZED PATIENTS
    Predrag, Stojanovic
    Branislava, Kocic
    Miodrag, Stojanovic
    Biljana, Miljkovic-Selimovic
    Suzana, Tasic
    Natasa, Miladinovic-Tasic
    Tatjana, Babic
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2012, 43 (01) : 215 - 223
  • [2] Prevention of Clostridium difficile infection in hamsters using a non-toxigenic strain
    de Oliveira Junior, Carlos Augusto
    Silveira Silva, Rodrigo Otavio
    Diniz, Amanda Nadia
    Pires, Prhiscylla Sadana
    Faria Lobato, Francisco Carlos
    de Assis, Ronie Antunes
    CIENCIA RURAL, 2016, 46 (05): : 853 - 859
  • [3] Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside
    Gerding, Dale N.
    Sambol, Susan P.
    Johnson, Stuart
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [4] Spore Production of Toxigenic and Non-Toxigenic Clostridium difficile Isolates in Sub-MIC of Vancomycin, Clindamycin, and Ceftazidime
    Zarandi, Ebrahim Rezazadeh
    Mansouri, Shahla
    Nakhaee, Nouzar
    Sarafzadeh, Farhad
    Moradi, Mohammad
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2019, 12 (05)
  • [5] Genomic basis of antimicrobial resistance in non-toxigenic Clostridium difficile in Southeast Asia
    Imwattana, Korakrit
    Kiratisin, Pattarachai
    Riley, Thomas V.
    Knight, Daniel R.
    ANAEROBE, 2020, 66
  • [6] New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C-difficile during daily ampicillin or ceftriaxone administration
    Merrigan, Michelle M.
    Sambol, Susan P.
    Johnson, Stuart
    Gerding, Dale N.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 : S46 - S50
  • [7] Non-toxigenic strain of Clostridioides difficile Z31 reduces the occurrence of C. difficile infection (CDI) in one-day-old piglets on a commercial pig farm
    Oliveira Junior, C. A.
    Silva, R. O. S.
    Lage, A. P.
    Coura, F. M.
    Ramos, C. P.
    Alfieri, A. A.
    Guedes, R. M. C.
    Lobato, F. C. F.
    VETERINARY MICROBIOLOGY, 2019, 231 : 1 - 6
  • [8] Electroporation of DNA sequences from the pathogenicity locus (PaLoc) of toxigenic Clostridium difficile into a non-toxigenic strain
    Ackermann, G
    Tang, YJ
    Henderson, JP
    Rodloff, AC
    Silva, J
    Cohen, SH
    MOLECULAR AND CELLULAR PROBES, 2001, 15 (05) : 301 - 306
  • [9] Risk Factors of Fecal Toxigenic or Non-Toxigenic Clostridium difficile Colonization: Impact of Toll-Like Receptor Polymorphisms and Prior Antibiotic Exposure
    Hung, Yuan-Pin
    Lin, Hsiao-Ju
    Wu, Tai-Chieh
    Liu, Hsiu-Chuan
    Lee, Jen-Chieh
    Lee, Chih-I
    Wu, Yi-Hui
    Wan, Lei
    Tsai, Pei-Jane
    Ko, Wen-Chien
    PLOS ONE, 2013, 8 (07):
  • [10] Patients with cystic fibrosis have a high carriage rate of non-toxigenic Clostridium difficile
    Bauer, M. P.
    Farid, A.
    Bakker, M.
    Hoek, R. A. S.
    Kuijper, E. J.
    van Dissel, J. T.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (07) : O446 - O449